Introducing the Recipients of the Incyte Ingenuity Awards in GVHD

The 2021 Recipients of the Incyte Ingenuity Awards in GVHD

Memorial Sloan Kettering Cancer Center logo

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center was awarded $100,000 to implement its project, the GVHD-Focused Telehealth Clinic.

The GVHD-Focused Telehealth Clinic will address inequities and expand access to GVHD care, by creating a multispecialty GVHD telehealth clinic for adult and pediatric patients with GVHD. This telehealth clinic aims to improve patient access to GVHD management and thereby improve their quality of life. The project also aims not only to improve access, by serving a wider and more diverse population of people with GVHD, but also to decrease GVHD-associated complications.

Aplastic Anemia and MDS International Foundation logo

Aplastic Anemia and MDS International Foundation

Aplastic Anemia and MDS International Foundation was awarded $35,000 to implement its project, GVHD Interactive Provider Network.

GVHD Interactive Provider Network will address the need for expert advice and mentoring by creating a space for disease specialists to connect with community-based providers. Through this network, these healthcare providers will be able to share expertise and discuss cases in order to improve care for patients with chronic GVHD, especially in practices outside of major academic centers. The Aplastic Anemia and MDS International Foundation will tackle this project by using proven adult learning techniques and interactive video technology in real-time collaborative sessions to help healthcare professionals gain the expertise required to provide needed services.

Both the GVHD-Focused Telehealth Clinic and GVHD Interactive Provider Network were selected by the judges because they embody the core mission of the Incyte Ingenuity Award program in fostering collaboration with the GVHD community to improve the lives of those living with GVHD.

In particular, the judges noted that the GVHD-Focused Telehealth Clinic demonstrated a high potential impact for the GVHD community by ensuring GVHD patients and their caregivers from all backgrounds are able to access advanced GVHD providers through a telehealth platform. Meanwhile, the GVHD Interactive Provider Network was selected as the judges deemed that the goal of transferring knowledge in managing GVHD is a worthy and valuable cause that tackles concerns of inequitable care that some GVHD patients may face.

We look forward to seeing these proposals come to fruition and the positive impact they will have on the GVHD community. Interested in learning about past winning projects? Click on the 2020 tab to read about the 2020 award recipient!

The Inaugural Recipient of the Incyte Ingenuity Award in GVHD

Massachusetts General Hospital Cancer Center logo

Massachusetts General Cancer Center

In September of 2020, Massachusetts General Cancer Center was awarded $100,000 to implement its project, Horizon Mobile App for Patients with GVHD.

This project will develop a patient-centered, multi-component mobile intervention app that aims to improve the quality of life and care of patients with chronic GVHD. The app will consist of an educational game, which will allow a patient character to navigate through a journey as they cope with their chronic GVHD and monitor their progress. The effectiveness of this app will be evaluated via a pilot program, with consideration for a larger expansion.

Horizon Mobile App for Patients with Chronic GVHD was selected by the judges because it embodies the core mission of the Incyte Ingenuity Award program in fostering collaboration with the community to improve the lives of those living with GVHD.

In particular, the judges noted that this project was the most well-developed application with a clear objective and realistic approach to improving the GVHD patient experience.

As the inaugural winner, we look forward to seeing this proposal come to fruition and the positive impact it will have on the GVHD community. As of now, the project is tracking to be completed by June, 2022.

2020 award recipient, Areej El-Jawahri, MD, explains her award-winning project and her experience working with GVHD patients.